APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s

Схожие документы

• Towards precision medicine in Alzheimer’s disease: deciphering genetic data to establish informative biomarkers
  по: Chiba-Falek, Ornit, et al.
  Опубликовано: (2017)
• Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer’s disease
  по: Angrist, Misha, et al.
  Опубликовано: (2020)
• Probing the role of PPARγ in the regulation of late-onset Alzheimer’s disease-associated genes
  по: Barrera, Julio, et al.
  Опубликовано: (2018)
• Bioinformatics pipeline to guide late‐onset Alzheimer's disease (LOAD) post‐GWAS studies: Prioritizing transcription regulatory variants within LOAD‐associated regions
  по: Michael W. Lutz, et al.
  Опубликовано: (2022-01-01)
• Shared Genetic Etiology Underlying Late-Onset Alzheimer’s Disease and Post Traumatic Stress Syndrome
  по: Lutz, Michael W., et al.
  Опубликовано: (2020)